Treating Staphylococcus aureus colonization in patients prior to surgery is a common step to prevent surgical site infections, but patients do not always follow the multistep application instructions ...

PHILADELPHIA & SYDNEY--(BUSINESS WIRE)--Clinical stage synthetic cannabinoid company Botanix Pharmaceuticals Limited has today published positive data from a world first human clinical study, ...

As mentioned earlier, there is an urgent need for the development of novel antibiotics targeting S. aureus. Fortunately, a number of new agents active against MRSA and other Gram-positive pathogens ...

A new class of engineered proteins may counter infection caused by Staphylococcus aureus -- a bacterial species considered one of the largest global health threats, a new study suggests. A new class ...

Anaturopath and Managing Director, LamboDebs Nature Clinic, Lagos, Dr Lambo Adebisi, has said staphylococcus aureus can be cured with herbs made from ginseng and other preparations. According to him, ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window An early switch to oral antibiotics in patients hospitalized ...

A National Institutes of Health (NIH)-supported clinical trial has found that the outcome of treating complicated Staphylococcus aureus bloodstream infections with two intravenous (IV) doses of the ...

THE purpose of this communication is to report an outbreak of staphylococcal infections on the Surgical Service of the Veterans Administration Hospital, Manchester, New Hampshire, the measures taken ...

Bacteria from cows has shown "promising" results in treating hospital superbugs. The farmyard favorites carry a microbe that ...

British physician and microbiologist Alexander Fleming, discoverer of penicillin nearly 100 years ago, was the first to warn ...

Staphylococcus bacteria live on skin and can cause a staph infection if they enter the bloodstream. Staph infections can involve a range of symptoms, like vomiting, rashes or inflamed skin, and fever.

YONKERS, N.Y., Oct. 26, 2020 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX) a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), ...